Association of TNF-α rs1800629, CASP3 rs72689236 and FCGR2A rs1801274 Polymorphisms with Susceptibility to Kawasaki Disease: A Comprehensive Meta-Analysis

References

• Sim BK, Park H, Kim J-J, Yun SW, Yu JJ, Yoon KL, Lee K-Y, Kil H-R, Kim GB, Han M-K, et al. Assessment of the clinical heterogeneity of Kawasaki disease using genetic variants of BLK and FCGR2A. Korean Circ J. 2019;49:99–108. doi:10.4070/kcj.2018.0224.
   PubMed Web of Science ®Google Scholar
• Nakamura Y. Kawasaki disease: epidemiology and the lessons from it. Int J Rheum Dis. 2018;21:16–19. doi:10.1111/1756-185X.13211.
   PubMed Web of Science ®Google Scholar
• Rowley AH, Shulman ST. The epidemiology and pathogenesis of Kawasaki disease. Front Pediatr. 2018;6. doi:10.3389/fped.2018.00374.
   PubMed Web of Science ®Google Scholar
• Menikou S, Langford PR, Levin M. Kawasaki disease: the role of immune complexes revisited. Front Immunol. 2019;10:1156. doi:10.3389/fimmu.2019.01156.
   PubMed Web of Science ®Google Scholar
• Cohen E, Sundel R. Kawasaki disease at 50 years. JAMA Pediatr. 2016;170:1093–1099. doi:10.1001/jamapediatrics.2016.1446.
   PubMed Web of Science ®Google Scholar
• Gupta A, Singh S. Kawasaki disease for dermatologists. Indian Dermatol Online J. 2016;7:461–470. doi:10.4103/2229-5178.193903.
   PubMedGoogle Scholar
• Nakamura A, Ikeda K, Hamaoka K. Aetiological significance of infectious stimuli in Kawasaki disease. Front Pediatr. 2019;7:244. doi:10.3389/fped.2019.00244.
   Web of Science ®Google Scholar
• Nagata S. Causes of Kawasaki disease-from past to present. Front Pediatr. 2019;7:18. doi:10.3389/fped.2019.00018.eCollection2019.
   PubMed Web of Science ®Google Scholar
• Chaudhary H, Nameirakpam J, Kumrah R, Pandiarajan V, Suri D, Rawat A, Singh S. Biomarkers for Kawasaki disease: clinical utility and the challenges ahead. Front Pediatr. 2019;7:242. doi:10.3389/fped.2019.00242.
   PubMed Web of Science ®Google Scholar
• Kamizono S, Yamada A, Higuchi T, Kato H, Itoh K. Analysis of tumor necrosis factor-α production and polymorphisms of the tumor necrosis factor-α gene in individuals with a history of Kawasaki disease. Pediatr Int. 1999;41:341–345. doi:10.1046/j.1442-200x.1999.01085.x.
   PubMed Web of Science ®Google Scholar
• Quasney MW, Bronstein DE, Cantor RM, Zhang Q, Stroupe C, Shike H, Bastian JF, Matsubara T, Fujiwara M, Akimoto K, et al. Increased frequency of alleles associated with elevated tumor necrosis factor-α levels in children with Kawasaki disease. Pediatr Res. 2001;49:686–690. doi:10.1203/00006450-200105000-00013.
   PubMed Web of Science ®Google Scholar
• Ahn S-Y, Jang G-C, Shin J-S, Shin KM, Kim D-S. Tumor necrosis factor-alpha levels and promoter polymorphism in patients with Kawasaki disease in Korea. Yonsei Med J. 2003;44:1021–1026. doi:10.3349/ymj.2003.44.6.1021.
   PubMed Web of Science ®Google Scholar
• Chien YH, Chang KW, Yang YH, Lu MY, Lin YT, Chiang BL. Association between levels of TNF-alpha and TNF-alpha promoter -308 A/A polymorphism in children with Kawasaki disease. J Formos Med Assoc. 2003;102:147–150. doi:10.29828/JFMA.200303.0003.
   PubMed Web of Science ®Google Scholar
• Yang J, Li C-R, Li Y-B, Li R-X, Sun L-B, Huang H-J, Wang G-B. The correlation between Kawasaki disease and polymorphisms of Tumor necrosis factor alpha and interleukin-10 gene promoter. Zhonghua Er Ke Za Zhi = Chin J Pediatr. 2003;41:598–602. [].
   PubMedGoogle Scholar
• Cheung Y-F, Huang G-y, Chen S-B, Liu X-Q, Xi L, Liang X-C, Huang M-R, Chen S, Huang L-S, Liu X-Q, et al. Inflammatory gene polymorphisms and susceptibility to kawasaki disease and its arterial sequelae. Pediatrics. 2008;122:e608–14. doi:10.1542/peds.2008-0646.
   PubMed Web of Science ®Google Scholar
• Weng K-P, Ho T-Y, Chiao Y-H, Cheng J-T, Hsieh K-S, Huang S-H, Ou S-F, Liu K-H, Hsu C-J, Lu P-J, et al. Cytokine genetic polymorphisms and susceptibility to Kawasaki disease in Taiwanese children. Circ J. 2010;74:2726–2733. doi:10.1253/circj.CJ-10-0542.
   PubMed Web of Science ®Google Scholar
• Cruz-Olivo F, García-Elorriaga G, González-Bonilla C, Del Rey-Pineda G, Mancilla-Ramírez J. Tumor necrosis factor -308 and lymphotoxin +252 polymorphisms in Mexican children with Kawasaki disease and coronary aneurysms. Archiv Med Res. 2011;42:602–607. doi:10.1016/j.arcmed.2011.11.002.
   PubMed Web of Science ®Google Scholar
• Maggioli E, Boiocchi C, Zorzetto M, Mannarino S, Bossi G, Cuccia M. HLA class III genes involvement in Kawasaki disease: a case-control study in Caucasian population. Int J Immunogenet. 2014;41:44–53. doi:10.1111/iji.12077.
   PubMed Web of Science ®Google Scholar
• Assari R, Aghighi Y, Ziaee V, Sadr M, Rahmani F, Rezaei A, Sadr Z, Moradinejad MH, Raeeskarami SR, Rezaei N, et al. Pro-inflammatory cytokine single nucleotide polymorphisms in Kawasaki disease. Int J Rheum Dis. 2018;21:1120–1126. doi:10.1111/1756-185X.12911.
   PubMed Web of Science ®Google Scholar
• Kuo H-C, Hsu Y-W, Wu C-M, Chen SH-Y, Hung K-S, Chang W-P, Yang KD, Hsieh K-S, Chen W-C, Onouchi Y, et al. A replication study for association of ITPKC and CASP3 two-locus analysis in IVIG unresponsiveness and coronary artery lesion in Kawasaki disease. PLoS One. 2013;8:e69685. doi:10.1371/journal.pone.0069685.
   PubMedGoogle Scholar
• Onouchi Y, Ozaki K, Buns JC, Shimizu C, Hamada H, Honda T, Terai M, Honda A, Takeuchi T, Shibuta S, et al. Common variants in CASP3 confer susceptibility to Kawasaki disease. Hum Mol Genet. 2010;19:2898–2906. doi:10.1093/hmg/ddq176.
   PubMed Web of Science ®Google Scholar
• Peng Q, Chen C, Wu Q, Li B, Liao J, Luo C, et al. Association of CASP3 gene single nucleotide polymorphisms with Kawasaki disease in Chinese children patients. Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chin J Med Genet. 2013;30:180–184. doi:10.3760/cma.j.issn.1003-9406.2013.04.013.
   PubMedGoogle Scholar
• Wc H-Y, Shu-Xiang L. Association of CASP3 gene polymorphism with Kawasaki disease susceptibility and coronary artery lesion. Shandong Med J. 2013;53:20–24.
   Google Scholar
• Taniuchi S, Masuda M, Teraguchi M, Ikemoto Y, Komiyama Y, Takahashi H, Kino M, Kobayashi Y. Polymorphism of Fcγ RIIa may affect the efficacy of γ-globulin therapy in Kawasaki disease. J Clin Immunol. 2005;25:309–313. doi:10.1007/s10875-005-4697-7.
   PubMed Web of Science ®Google Scholar
• Biezeveld M, Geissler J, Merkus M, Kuipers IM, Ottenkamp J, Kuijpers T. The involvement of Fc gamma receptor gene polymorphisms in Kawasaki disease. Clin Exp Immunol. 2006;147:106–111. doi:10.1111/j.1365-224903266.x.
   Web of Science ®Google Scholar
• Khor CC, Hong Kong–Shanghai Kawasaki Disease Genetics Consortium, Davila S, Breunis WB, Lee Y-C, Shimizu C, Wright VJ, Yeung RSM, Tan DEK, Sim KS, Wang JJ, et al. Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat Genet. 2011;43:1241–1246. doi:10.1038/ng.981.
   PubMed Web of Science ®Google Scholar
• Ji YX, Zhang HY, Lin SX. Single nucleotide polymorphism of FCGR2A gene in Han Chinese children with Kawasaki disease. Chin J Contemporary Pediatr. 2013;15:196–200. doi:10.7499/j.issn.1008-8830.2013.03.008.
   Google Scholar
• Yan Y, Ma Y, Liu Y, Hu H, Shen Y, Zhang S, Ma Y, Tao D, Wu Q, Peng Q, et al. Combined analysis of genome-wide-linked susceptibility loci to Kawasaki disease in Han Chinese. Hum Genet. 2013;132:669–680. doi:10.1007/s00439-013-1279-2.
   PubMed Web of Science ®Google Scholar
• Chatzikyriakidou A, Georgiou I, Voulgari PV, Drosos AA. The role of tumor necrosis factor (TNF)-alpha and TNF receptor polymorphisms in susceptibility to ankylosing spondylitis. Clin Exp Rheumatol. 200927:645–648.
   PubMed Web of Science ®Google Scholar
• Lou J, Zhong R, Shen N, Lu X-Z, Ke J-T, Duan J-y, Qi Y-Q, Wang Y-J, Zhang Q, Wang W, et al. Systematic confirmation study of GWAS-identified genetic variants for Kawasaki disease in a Chinese population. Sci Rep. 2015;5:8194. doi:10.1038/srep08194.
   PubMed Web of Science ®Google Scholar
• Aslebahar F, Neamatzadeh H, Meibodi B, Karimi-Zarchi M, Tabatabaei RS, Noori-Shadkam M, et al. Association of tumor necrosis factor-α (TNF-α) −308G > A and −238G > A polymorphisms with recurrent pregnancy loss risk: a meta-analysis. Int J Fertil Sterility. 2019;12:284–292. doi:10.22074/ijfs.2019.5454.
   PubMed Web of Science ®Google Scholar
• Farbod M, Karimi-Zarchi M, Heiranizadeh N, Seifi-Shalamzari N, Akbarian-Bafghi MJ, Jarahzadeh MH, Neamatzadeh H. Association of TNF-α -308G > a polymorphism with susceptibility to cervical cancer and breast cancer – a systematic review and meta-analysis. Klin Onkol. 2019;32:170–180. doi:10.14735/amko2019170.
   PubMedGoogle Scholar
• Azarpira MR, Ghilian MM, Sobhan MR, Mehdinezhad-Yazdi M, Aghili K, Miresmaeili SM, Neamatzadeh H. Association of MTHFR and TNF-α genes polymorphisms with susceptibility to Legg-Calve-Perthes disease in Iranian children: a case-control study. J Orthop. 2018;15:984–987. doi:10.1016/j.jor.2018.08.042.
   PubMed Web of Science ®Google Scholar
• Associations of Caspase-3 gene polymorphism with lumbar disc herniation- ClinicalKey n.d. [accessed 2019 Oct 28]. https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S1607551X16301930?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1607551X16301930%3Fshowall%3Dtrue&referrer=https:%2F%2Fwww.ncbi.nlm.nih.gov%2F.
   Google Scholar
• Yan S, Li YZ, Zhu XW, Liu CL, Wang P, Liu YL. HuGE systematic review and meta-analysis demonstrate association of CASP-3 and CASP-7 genetic polymorphisms with cancer risk. Genet Mol Res. 2013;12:1561–1573. doi:10.4238/2013.May.13.10.
   PubMed Web of Science ®Google Scholar
• Xing Y, Wang H, Liu X, Yu X, Chen R, Wang C, Yu X, Sun L. Meta-analysis of the relationship between single nucleotide polymorphism rs72689236 of caspase-3 and Kawasaki disease. Mol Biol Rep. 2014;41:6377–6381. doi:10.1007/s11033-014-3517-7.
   PubMed Web of Science ®Google Scholar
• Peng Q, Chen C-H, Wu Q, Yang Y. Association of new functional SNP rs72689236 of CASP3 with Kawasaki disease: a meta-analysis. Zhongguo Dang Dai Er Ke Za Zhi = Chin J Contemporary Pediatr. 2013;15:477–483.
   PubMedGoogle Scholar
• Lin L, Wang SY, Yang SB, Xiao FC. Association between the FCGR2A gene H131R polymorphism and risk of Kawasaki disease: a meta-analysis. Genet Mol Res. 2015;14:6256–6264. doi:10.4238/2015.June.9.12.
   PubMedGoogle Scholar
• Moghimi M, Sobhan MR, Jarahzadeh MH, Morovati-Sharifabad M, Aghili K, Ahrar H, Zare-Shehneh M, Neamatzadeh H. Association of GSTM1, GSTT1, GSTM3, and GSTP1 genes polymorphisms with susceptibility to osteosarcoma: a case- control study and meta-analysis. Asian Pac J Cancer Prev. 2019;20:675–682. doi:10.31557/APJCP.2019.20.3.675.
   PubMedGoogle Scholar
• Aflatoonian M, Moghimi M, Akbarian-Bafghi MJ, Morovati-Sharifabad M, Jarahzadeh MH, Neamatzadeh H. Association of TNF- α-308G > A polymorphism with susceptibility to celiac disease: a systematic review and meta-analysis. Arq Gastroenterol. 2019;56:88–94. doi:10.1590/s0004-2803.201900000-20.
   PubMedGoogle Scholar
• Mirjalili SA, Moghimi M, Aghili K, Jafari M, Abolbaghaei SM, Neamatzadeh H, Mazaheri M, Zare-Shehneh M. Association of promoter region polymorphisms of interleukin-10 gene with susceptibility to colorectal cancer: a systematic review and meta-analysis. Arq Gastroenterol. 2018;55:306–313. doi:10.1590/s0004-2803.201800000-66.
   PubMedGoogle Scholar
• Moghimi M, Kargar S, Jafari MA, Ahrar H, Jarahzadeh MH, Neamatzadeh H, Sadeghizadeh-Yazdi J. Angiotensin converting enzyme insertion/deletion polymorphism is associated with breast cancer risk: a meta-analysis. Asian Pac J Cancer Prev. 2018;19:3225–3231. doi:10.31557/APJCP.2018.19.11.3225.
   PubMedGoogle Scholar
• Sobhan MR, Mahdinezhad-Yazdi M, Moghimi M, Aghili K, Jafari M, Zare-Shehneh M, et al. Plasminogen activator inhibitor-1 4G/5G polymorphism contributes to osteonecrosis of the femoral head susceptibility: evidence from a systematic review and meta-analysis. Archiv Bone Joint Surg. 2018;6:468–477.
   PubMedGoogle Scholar
• Jafari-Nedooshan J, Moghimi M, Zare M, Heiranizadeh N, Morovati-Sharifabad M, Akbarian-Bafghi MJ, Jarahzadeh MH, Neamatzadeh H. Association of promoter region polymorphisms of IL-10 gene with susceptibility to lung cancer: systematic review and meta-analysis. Asian Pac J Cancer Prev. 2019;20:1951–1957. doi:10.31557/APJCP.2019.20.7.1951.
   PubMedGoogle Scholar